Ming Teng

3.0k total citations · 2 hit papers
45 papers, 2.3k citations indexed

About

Ming Teng is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ming Teng has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Ming Teng's work include Dialysis and Renal Disease Management (9 papers), Vitamin D Research Studies (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Ming Teng is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Vitamin D Research Studies (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Ming Teng collaborates with scholars based in United States, Australia and China. Ming Teng's co-authors include J. Michael Lazarus, Myles Wolf, Ravi Thadhani, Norma J. Ofsthun, Edmund G. Lowrie, Carlos A. Camargo, Miguel A. Hernán, Eduardo Lacson, Raymond M. Hakim and Gary C. Curhan and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming Teng

41 papers receiving 2.2k citations

Hit Papers

Survival of Patients Undergoing Hemodialysis with Parical... 2003 2026 2010 2018 2003 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Teng United States 16 1.5k 927 385 367 333 45 2.3k
María Eugênia Fernandes Canziani Brazil 23 1.7k 1.1× 430 0.5× 121 0.3× 276 0.8× 461 1.4× 76 2.2k
Charles R. Swanepoel South Africa 21 1.0k 0.7× 118 0.1× 177 0.5× 186 0.5× 185 0.6× 62 1.6k
James A. Sloand United States 24 1.1k 0.7× 174 0.2× 100 0.3× 309 0.8× 40 0.1× 73 2.4k
Joseph M. Messana United States 22 1.1k 0.7× 117 0.1× 129 0.3× 269 0.7× 67 0.2× 64 2.2k
Kevin Meyers United States 30 603 0.4× 138 0.1× 451 1.2× 315 0.9× 144 0.4× 108 2.4k
Dong Chan Jin South Korea 26 959 0.6× 102 0.1× 96 0.2× 256 0.7× 48 0.1× 78 2.0k
Norio Hanafusa Japan 26 974 0.6× 70 0.1× 91 0.2× 278 0.8× 72 0.2× 138 2.0k
Steven McTaggart Australia 24 432 0.3× 100 0.1× 619 1.6× 287 0.8× 46 0.1× 61 2.4k
Lale Sever Türkiye 22 651 0.4× 76 0.1× 219 0.6× 259 0.7× 58 0.2× 88 1.6k
Smeeta Sinha United Kingdom 23 829 0.5× 153 0.2× 95 0.2× 296 0.8× 215 0.6× 96 1.6k

Countries citing papers authored by Ming Teng

Since Specialization
Citations

This map shows the geographic impact of Ming Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Teng more than expected).

Fields of papers citing papers by Ming Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Teng. The network helps show where Ming Teng may publish in the future.

Co-authorship network of co-authors of Ming Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Teng. A scholar is included among the top collaborators of Ming Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Teng. Ming Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teng, Ming, Jiang Chang, Yang Chen, et al.. (2025). Engineering encapsulated living bacteria for advanced healthcare management. Biotechnology Advances. 83. 108640–108640. 2 indexed citations
3.
4.
Zhang, Jingquan, Dian Wang, Peng Li, et al.. (2021). Application of an improved particle filter for random seismic noise suppression. Journal of Geophysics and Engineering. 18(6). 943–953. 1 indexed citations
5.
Jensen, Eric H., et al.. (2012). Meta-analysis of Bioabsorbable Staple Line Reinforcement and Risk of Fistula Following Pancreatic Resection. Journal of Gastrointestinal Surgery. 17(2). 267–272. 28 indexed citations
6.
Wolf, Myles, Joseph R. Betancourt, Yuchiao Chang, et al.. (2008). Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients. Journal of the American Society of Nephrology. 19(7). 1379–1388. 135 indexed citations
7.
Lacson, Eduardo, John Rogus, Ming Teng, J. Michael Lazarus, & Raymond M. Hakim. (2008). The Association of Race With Erythropoietin Dose in Patients on Long-term Hemodialysis. American Journal of Kidney Diseases. 52(6). 1104–1114. 28 indexed citations
8.
Teng, Ming, Alex Hariz, Hung-Yao Hsu, & Taher Omari. (2008). Carbon nanotubes on polymer-based pressure micro-sensor for manometric catheters. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7269. 726911–726911. 1 indexed citations
9.
Mishler, Rick, Jeffrey J. Sands, Norma J. Ofsthun, et al.. (2006). Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments. Kidney International. 69(2). 393–398. 33 indexed citations
10.
Williams, Margiad, Eduardo Lacson, Ming Teng, Norma J. Ofsthun, & J. Michael Lazarus. (2006). Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney International. 70(8). 1503–1509. 134 indexed citations
11.
Li, Hecheng, Jeffrey M. Albert, Eric T. Shinohara, et al.. (2006). E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients. Urologic Oncology Seminars and Original Investigations. 24(6). 496–502. 3 indexed citations
12.
Shinohara, Eric T., Qiuyin Cai, Regina Courtney, et al.. (2006). Plasminogen Activator Inhibitor-1 Promoter Polymorphism is Not Associated With the Aggressiveness of Disease in Prostate Cancer. Clinical Oncology. 18(4). 333–337. 5 indexed citations
13.
Lacson, Eduardo, et al.. (2005). Antibody response to Engerix‐B® and Recombivax‐HB® hepatitis B vaccination in end‐stage renal disease. Hemodialysis International. 9(4). 367–375. 38 indexed citations
14.
Tedesco, Karen L., Jordan Berlin, Charles D. Blanke, et al.. (2005). Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1364–1370. 1 indexed citations
15.
Shinohara, Eric T., Hui Cai, Carolyn Cao, et al.. (2005). Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer. Disease Markers. 21(1). 37–41. 10 indexed citations
16.
Teng, Ming, Myles Wolf, J. Michael Lazarus, et al.. (2005). Activated Injectable Vitamin D and Hemodialysis Survival. Journal of the American Society of Nephrology. 16(4). 1115–1125. 589 indexed citations breakdown →
17.
Knight, Eric L., Norma J. Ofsthun, Ming Teng, J. Michael Lazarus, & Gary C. Curhan. (2003). The association between mental health, physical function, and hemodialysis mortality. Kidney International. 63(5). 1843–1851. 199 indexed citations
18.
Lowrie, Edmund G., Ming Teng, Nancy L. Lew, et al.. (2003). Toward a Continuous Quality Improvement Paradigm for Hemodialysis Providers with Preliminary Suggestions for Clinical Practice Monitoring and Measurement. Hemodialysis International. 7(1). 28–51. 7 indexed citations
19.
Lacson, Eduardo, Ming Teng, J. Michael Lazarus, et al.. (2001). Limitations of the Facility-Specific Standardized Mortality Ratio for Profiling Health Care Quality in Dialysis. American Journal of Kidney Diseases. 37(2). 267–275. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026